Skip to content

    Recently Viewed


      Why drug-resistant TB matters to the world

      Share Article
      share to

      Beyond its devastating impact on human lives, DR-TB takes a tremendous economic toll. The EIU analysis shows that, based on current incidence and prevalence rates, DR-TB deaths in a single year are estimated to cost the global economy at least US $17.8 billion.

      Learn more about the report here.

      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.